These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 18231895)

  • 21. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of prognostic factors and patterns of recurrence in patients with pathologic stage III endometrial cancer.
    Patel S; Portelance L; Gilbert L; Tan L; Stanimir G; Duclos M; Souhami L
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1438-45. PubMed ID: 17418961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Routine pelvic lymphadenectomy in apparently early stage endometrial cancer.
    Zuurendonk LD; Smit RA; Mol BW; Feijen HW; de Graaff J; Sykora D; de Winter KA; vd Wurff A; Snijders MP; Kruitwagen RF
    Eur J Surg Oncol; 2006 May; 32(4):450-4. PubMed ID: 16546343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer.
    Goudge C; Bernhard S; Cloven NG; Morris P
    Gynecol Oncol; 2004 May; 93(2):536-9. PubMed ID: 15099975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
    Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
    Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical review of 97 patients with endometrial stromal sarcoma].
    Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):115-9. PubMed ID: 18683750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of failures in patients with FIGO stage IIIc1-IIIc2 endometrial cancer.
    Gadducci A; Cosio S; Fabrini MG; Guerrieri ME; Greco C; Genazzani AR
    Anticancer Res; 2012 Jan; 32(1):201-5. PubMed ID: 22213308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy.
    Descamps P; Calais G; Moire C; Bertrand P; Castiel M; Le Floch O; Lansac J; Body G
    Gynecol Oncol; 1997 Jan; 64(1):54-8. PubMed ID: 8995547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients.
    Röper B; Astner ST; Heydemann-Obradovic A; Thamm R; Jacob V; Hölzel D; Schmalfeldt B; Kiechle-Bahat M; Höss C; Molls M
    Gynecol Oncol; 2007 Dec; 107(3):541-8. PubMed ID: 17884152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma.
    Nofech-Mozes S; Ackerman I; Ghorab Z; Ismiil N; Thomas G; Covens A; Khalifa MA
    Am J Clin Pathol; 2008 Jun; 129(6):912-7. PubMed ID: 18480008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy.
    Mariani A; Dowdy SC; Keeney GL; Long HJ; Lesnick TG; Podratz KC
    Gynecol Oncol; 2004 Oct; 95(1):120-6. PubMed ID: 15385120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Keys HM; Roberts JA; Brunetto VL; Zaino RJ; Spirtos NM; Bloss JD; Pearlman A; Maiman MA; Bell JG;
    Gynecol Oncol; 2004 Mar; 92(3):744-51. PubMed ID: 14984936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients.
    Chan JK; Cheung MK; Huh WK; Osann K; Husain A; Teng NN; Kapp DS
    Cancer; 2006 Oct; 107(8):1823-30. PubMed ID: 16977653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer.
    Briët JM; Hollema H; Reesink N; Aalders JG; Mourits MJ; ten Hoor KA; Pras E; Boezen HM; van der Zee AG; Nijman HW
    Gynecol Oncol; 2005 Mar; 96(3):799-804. PubMed ID: 15721428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of recurrence in surgical stage II endometrial adenocarcinoma.
    Feltmate CM; Duska LR; Chang Y; Flynn CE; Nikrui N; Kiggundu E; Goodman A; Fuller AF; McIntyre JF
    Gynecol Oncol; 1999 Jun; 73(3):407-11. PubMed ID: 10366468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
    Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
    Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of pelvic lymphadenectomy in surgical treatment of apparent stage I endometrial cancer.
    Ceccaroni M; Savelli L; Bovicelli A; Alboni C; Ceccarini M; Farina A; Bovicelli L
    Anticancer Res; 2004; 24(3b):2073-8. PubMed ID: 15274403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer.
    Parthasarathy A; Kapp DS; Cheung MK; Shin JY; Osann K; Chan JK
    Obstet Gynecol; 2007 Dec; 110(6):1237-43. PubMed ID: 18055715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.